Drommi, F.; Calabrò, A.; Vento, G.; Pezzino, G.; Cavaliere, R.; Omero, F.; Muscolino, P.; Granata, B.; D’Anna, F.; Silvestris, N.;
et al. Crosstalk between ILC3s and Microbiota: Implications for Colon Cancer Development and Treatment with Immune Check Point Inhibitors. Cancers 2023, 15, 2893.
https://doi.org/10.3390/cancers15112893
AMA Style
Drommi F, Calabrò A, Vento G, Pezzino G, Cavaliere R, Omero F, Muscolino P, Granata B, D’Anna F, Silvestris N,
et al. Crosstalk between ILC3s and Microbiota: Implications for Colon Cancer Development and Treatment with Immune Check Point Inhibitors. Cancers. 2023; 15(11):2893.
https://doi.org/10.3390/cancers15112893
Chicago/Turabian Style
Drommi, Fabiana, Alessia Calabrò, Grazia Vento, Gaetana Pezzino, Riccardo Cavaliere, Fausto Omero, Paola Muscolino, Barbara Granata, Federica D’Anna, Nicola Silvestris,
and et al. 2023. "Crosstalk between ILC3s and Microbiota: Implications for Colon Cancer Development and Treatment with Immune Check Point Inhibitors" Cancers 15, no. 11: 2893.
https://doi.org/10.3390/cancers15112893
APA Style
Drommi, F., Calabrò, A., Vento, G., Pezzino, G., Cavaliere, R., Omero, F., Muscolino, P., Granata, B., D’Anna, F., Silvestris, N., De Pasquale, C., Ferlazzo, G., & Campana, S.
(2023). Crosstalk between ILC3s and Microbiota: Implications for Colon Cancer Development and Treatment with Immune Check Point Inhibitors. Cancers, 15(11), 2893.
https://doi.org/10.3390/cancers15112893
